The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.


Torrential rains brought by Japan typhoon kill 2, NHK says
Thousands of US flights halted before telecom problem resolved
UK's Burnham agrees to Saudi request for refuelling support
MS NOW, CNN and Politico to sue over White House ban
Pakistan says it killed 28 militants, Afghan Taliban and UN report 3 civilian deaths
